Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisoneJosé‐Tomás Navarro, Evarist Feliú, Josep‐María Ribera et al.|British Journal of Haematology|2001Cited by 104
Hepatosplenic T-Gammadelta Lymphoma in a Patient with Crohn's Disease Treated with AzathioprineJosé‐Tomás Navarro, Evarist Feliú, Josep‐María Ribera et al.|Leukemia & lymphoma/Leukemia and lymphoma|2003Cited by 81
International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients.José‐Tomás Navarro, Evarist Feliú, Josep‐María Ribera et al.|PubMed|1998Cited by 62
Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.José‐Tomás Navarro, Evarist Feliú, José‐Ángel Hernández‐Rivas et al.|PubMed|1998Cited by 59
HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy eraMaria João Baptista, José‐Tomás Navarro, Olga García et al.|AIDS|2015Cited by 50